Trendlines completed the acquisition of a 73.1% stake in OrthoSpin for $80m.

The Trendlines Group, a private equity firm, completed the acquisition of a 73.1% stake in OrthoSpin, an orthopedics company, for $80m. "I am delighted to announce this news. I'm extremely proud of the team that succeeded in meeting critical and complex tasks during a worldwide pandemic and wish to thank all our partners who supported us throughout the journey. I look forward to continuing our journey with DePuy Synthes to bring a real revolution to the hexapod bone deformity market," Oren Cohen, OrthoSpin CEO.